|
|
Article: In a New Study Actonel(R) 35 mg Once-a-Week Was as Effective as 5 mg Daily In Postmenopausal Women.
- Article from:
- PR Newswire
- Article date:
- November 12, 2001
CopyrightCOPYRIGHT 2001 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
SAN FRANCISCO, Nov. 12 /PRNewswire/ --
A once-a-week dosage of Actonel(R) (risedronate sodium tablets) 35 mg was as effective as daily Actonel 5 mg at increasing bone mineral density (BMD) in women with postmenopausal osteoporosis (PMO), in a recent study. Data from the study, which included 1,456 women age 50 and older, were presented today at the 65th Annual Scientific Meeting of the American College of Rheumatology in San Francisco.
(Logo: http://www.newscom.com/cgi-bin/prnh/20000501/NYM197 )
In the study, patients taking Actonel 35 mg once a week experienced a significant 3.9 percent increase in lumbar spine BMD at 12 months versus ...